Back to Search
Start Over
BASELINE CHARACTERISTICS FROM A PHASE 3, RANDOMIZED CONTROLLED TRIAL (COUGH-2) OF GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN REFRACTORY OR UNEXPLAINED CHRONIC COUGH
- Source :
- Chest; June 2020, Vol. 157 Issue: 6, Number 6 Supplement 1 pA4-A4, 1p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 00123692 and 19313543
- Volume :
- 157
- Issue :
- 6, Number 6 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Chest
- Publication Type :
- Periodical
- Accession number :
- ejs53796033
- Full Text :
- https://doi.org/10.1016/j.chest.2020.05.005